Ebv vaccine using gp350 antigen

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/12 (2006.01) A61K 39/245 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2484645

The invention relates to the use of an EBV membrane antigen or derivative thereof in combination with a suitable adjuvant in the manufacture of a vaccine for the prevention of infectious mononucleosis (IM), and to vaccine compositions suitable for prevention of IM.

L'invention concerne l'utilisation d'un antigène d'enveloppe du virus Epstein-Barr (EBV) ou un de ses dérivés en association avec un adjuvant approprié, pour produire un vaccin utilisé pour la prévention de la mononucléose infectieuse (IM). L'invention concerne également des compositions de vaccins convenant pour la prévention de la mononucléose infectieuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ebv vaccine using gp350 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ebv vaccine using gp350 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ebv vaccine using gp350 antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1909872

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.